Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
TREMELIMUMAB-ACTL 20 MG/ML INTRAVENOUS SOLUTION (OTHER 218328) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved June 28, 2026 , from http://ppman.hank.ai/transparency/procedure/218328/by-state?code_type=OTHER
“TREMELIMUMAB-ACTL 20 MG/ML INTRAVENOUS SOLUTION (OTHER 218328) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/218328/by-state?code_type=OTHER. Accessed
June 28, 2026 .
“TREMELIMUMAB-ACTL 20 MG/ML INTRAVENOUS SOLUTION (OTHER 218328) by State,” HANK Price Transparency ,
accessed June 28, 2026 ,
http://ppman.hank.ai/transparency/procedure/218328/by-state?code_type=OTHER.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
OTHER · across United States
218328 — Tremelimumab-actl 20 Mg/ml Intravenous Solution
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$80,296
National median
$15,745 – $94,794
IQR (p25 – p75)
7
hospitals filing
4
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 218328 (OTHER), with interquartile range
State Median p25 p75
CO $173,782 $128,126 $183,126
UT $80,296 $71,932 $88,282
MT $15,399 $12,855 $180,634
CA $462 $420 $532